v3.25.2
STOCKHOLDERS' DEFICIT - Awards granted (Details)
$ in Millions
3 Months Ended 6 Months Ended
Feb. 19, 2025
shares
Feb. 22, 2024
shares
Jun. 30, 2025
USD ($)
tranche
item
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
tranche
item
shares
Jun. 30, 2024
USD ($)
STOCKHOLDERS' EQUITY            
Stock-based compensation expense | $     $ 6.0 $ 4.5 $ 11.7 $ 8.8
Board of Director            
STOCKHOLDERS' EQUITY            
Stock-based compensation expense | $       1.0 $ 1.3 1.0
2024 Performance share award            
STOCKHOLDERS' EQUITY            
Granted (in shares)         774,203  
Stock value | $     2.8   $ 2.8  
2025 Performance share award | Members of management and executive officers | 2025 Tranche Year            
STOCKHOLDERS' EQUITY            
Granted (in shares)         1,216,944  
Stock value | $     4.3   $ 4.3  
2025 Performance share award | Members of management and executive officers | 2026 Tranche Year            
STOCKHOLDERS' EQUITY            
Granted (in shares)         108,323  
Stock value | $     0.4   $ 0.4  
2023 Performance share award            
STOCKHOLDERS' EQUITY            
Granted (in shares)         105,099  
Percentage of performance target         100.00%  
Stock value | $     0.4   $ 0.4  
RSU and PSU Units            
STOCKHOLDERS' EQUITY            
Percentage of Adjusted EBITDA Target         100.00%  
Percentage of free cash flow target         100.00%  
Restricted stock unit            
STOCKHOLDERS' EQUITY            
Stock-based compensation expense | $     $ 3.6 2.7 $ 6.2 4.8
Performance Vesting | Members of management and executive officers            
STOCKHOLDERS' EQUITY            
Granted (in shares)         3,650,970  
Number of tranches | tranche     3   3  
Number of performance targets | item     3   3  
Awards to be granted upon achieving 100% of performance target (in shares)         3,650,970  
Performance Vesting | Members of management and executive officers | Company does not achieve at least 80% of the Tranche            
STOCKHOLDERS' EQUITY            
Shares vested         0  
Performance Vesting | Members of management and executive officers | Minimum            
STOCKHOLDERS' EQUITY            
PSUs vesting as a percentage of performance target         80.00%  
Percentage of performance target         50.00%  
Number of strategic initiatives | item         3  
Number of strategic initiatives vesting of second tranche | item         4  
Performance Vesting | Members of management and executive officers | Maximum            
STOCKHOLDERS' EQUITY            
PSUs vesting as a percentage of performance target         120.00%  
Percentage of performance target         200.00%  
Number of strategic initiatives | item         7  
Number of strategic initiatives vesting of second tranche | item         10  
Performance stock unit expense            
STOCKHOLDERS' EQUITY            
Stock-based compensation expense | $     $ 2.4 $ 0.7 $ 3.2 0.8
Special award            
STOCKHOLDERS' EQUITY            
Shares vested 270,093 478,055        
Stock-based compensation expense | $         1.0 $ 2.1
Expected performance target to be achieved (as a percent) 146.00% 200.00%        
Cash settled units            
STOCKHOLDERS' EQUITY            
Shares vested 4,181 21,829        
Equity settled units            
STOCKHOLDERS' EQUITY            
Shares vested 265,912 456,226        
2024 Equity Incentive Plan            
STOCKHOLDERS' EQUITY            
Conversion of convertible securities (in shares) 1          
2024 Equity Incentive Plan | Restricted stock unit | Members of management            
STOCKHOLDERS' EQUITY            
Grant date fair value (in dollars) | $         $ 11.1  
Granted (in shares)         3,109,351  
Vesting period (in years)         3 years  
Vesting rights percentage         33.00%  
Number of days from the termination of service for settlement of fully vested units         30 days  
2024 Equity Incentive Plan | Performance Vesting | Members of management and executive officers            
STOCKHOLDERS' EQUITY            
Percentage of performance target         100.00%  
Common Stock | Board of Director            
STOCKHOLDERS' EQUITY            
Shares issued through at-the-market offering         370,586  
Grant date fair value (in dollars) | $         $ 1.3